Meyka AI API is live for developers.Start building.
Advertisement
Avanos Medical, Inc.

Avanos Medical, Inc. (AVNS) Stock Overview

Explore Avanos Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AVNS●NYSE
HealthcareMedical - Devices
$25.05
$0.05(0.20%)
U.S. Market opens in 52h 42m
Advertisement

Avanos Medical, Inc. (AVNS)

Meyka AI Score

Z

Key Financials

Market Cap1.2B
P/E Ratio-16.75
EPS (TTM)$-1.60
ROE-0.09%
Fundamental Analysis

AI Price Forecasts

1 Month$12.01
3 Months$17.86
1 Year Target$6.51

AVNS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Avanos Medical, Inc. (AVNS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 83.27, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $6.51.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -16.75 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.22%
5-Day Change
1.11%
1-Month Change
1.44%
3-Month Change
81.69%
6-Month Change
122.51%
Year-to-Date (YTD) Change
123.11%
1-Year Change
103.20%
3-Year Change
1.85%
5-Year Change
-36.89%
All-Time (Max) Change
-38.89%

Contact Information

https://avanos.com
844 428 2667
5405 Windward Parkway, Alpharetta, GA, 30004

Company Facts

2,227 Employees
IPO DateOct 21, 2014
CountryUS
Actively Trading

Frequently Asked Questions